Omixon & PIRCHE® collaborate on Epitope Determination with NGS

Global molecular diagnostics company Omixon, headquartered in Budapest, and technology company PIRCHE AG, headquartered in Berlin announce a collaboration to deliver the first integrated epitope determination and matching service that leverages whole gene consensus sequences assembled from NGS data of the HLA region. For the first time, fully characterized...

 

Read more

Omixon at BSHI 2018 – Cardiff, Wales, September 5-6

Join our small team, Afshan Ali (Sales Manager, EMEA) and Dr. Libor Kolesár (Field Application Scientist) for our Lunchtme Workshop on Friday, September 6 from 12:40 and learn more about the big question: whether laboratories should be pooling resources and scaling up in regional testing centres to achieve economies...

 

Read more